
Loading, please wait...

Loading, please wait...

Managing advanced Parkinson's disease requires timely clinical intervention to preserve patient functional independence and overall quality of life. Subthalamic nucleus deep brain stimulation remains one of the most effective surgical options for medically refractory motor fluctuations. However, accumulating clinical data reveal a troubling deep brain stimulation disparity between male and female patients. Although both sexes gain significant symptomatic relief from the procedure, systematic inequalities persist across surgical referral timing, baseline disease severity, and longitudinal outcomes. Recent multicenter and retrospective evaluations highlight that women often access advanced surgical therapies much later in their disease trajectory than men. Consequently, female candidates frequently present with greater disability, severe motor complications, and lower health-related quality of life scores at baseline. Addressing these sex-specific discrepancies is critical for movement disorder specialists, neurosurgeons, and primary care physicians aiming to optimize surgical candidacy and therapeutic equity.
A landmark retrospective cohort study evaluated ninety-four patients who received bilateral subthalamic nucleus deep brain stimulation over a fifteen-year period. The cohort comprised sixty-eight men and twenty-six women, reflecting a substantial gender imbalance in surgical uptake. This disproportionate male-to-female ratio mirrors trends consistently reported across global surgical centers. Researchers sought to evaluate sex differences across motor symptoms, dopaminergic medication requirements, and validated quality of life metrics before surgery and at one-year follow-up.
Motor function was quantified using the Unified Parkinson's Disease Rating Scale Part III, while medication burden was evaluated via levodopa equivalent daily dose. Additionally, researchers tracked multidimensional functional outcomes using the 39-Item Parkinson's Disease Questionnaire. Statistical evaluations utilized exploratory linear mixed-effect models to determine significant sex and time interactions. Therefore, this rigorous analytical framework provided objective insight into how sex influences surgical timelines and rehabilitation trajectories. Ultimately, the investigation confirmed that profound disparities exist in clinical presentations, even when both sexes achieve robust motor benefits from neurostimulation.
Preoperative assessments revealed stark physiological and functional contrasts between female and male surgical candidates. Specifically, female patients presented with a significantly longer duration of Parkinson's disease prior to undergoing surgery compared to male peers. Furthermore, women exhibited substantially higher off-medication motor scores, demonstrating more pronounced baseline motor disability. Despite having more severe motor impairment, female candidates paradoxically received lower baseline levodopa equivalent daily doses than men.
Moreover, female participants reported significantly poorer overall baseline quality of life scores across multiple health domains. These findings strongly suggest that women endure prolonged disease progression before receiving specialized evaluation for surgical device therapy. Clinicians frequently miss the optimal therapeutic window for female patients due to underestimating symptom burden or hesitations surrounding surgical invasiveness. In contrast, men typically receive earlier specialty evaluations and faster pathways to surgical consideration. Consequently, female candidates must cope with advanced motor degradation and substantial functional deficits for several years longer before accessing device-aided therapies.
At one year following surgery, both male and female patients demonstrated marked, comparable improvements in motor function. When evaluating off-medication and on-stimulation states, researchers found no significant interaction between sex and time for motor scores. Similarly, both cohorts achieved equivalent reductions in postoperative dopaminergic medication requirements. Therefore, the physiological efficacy of subthalamic nucleus stimulation in suppressing motor symptoms remains robust across both sexes.
However, diverging outcomes emerged within specific non-motor domains after surgery. Even after adjusting for baseline age, disease duration, preoperative motor severity, and medication dosage, a significant sex-by-time interaction appeared in cognitive health. Female patients experienced notable cognitive decline on standardized quality of life measures at the one-year mark. In contrast, male participants maintained comparatively stable cognitive scores. Because advanced baseline disease duration strongly correlates with cognitive vulnerability, delayed referral may expose women to heightened risks of postoperative cognitive decline. Consequently, clinicians must recognize that identical surgical procedures may trigger disparate non-motor trajectories when baseline disease stages differ.
Several multifaceted mechanisms contribute to the persistent gender gap observed in advanced Parkinson's disease therapies. First, neurobiological differences in dopamine metabolism, estrogen levels, and symptom phenomenology shape clinical presentations differently in women. Women often present with tremor-dominant phenotypes or early levodopa-induced dyskinesias, which can complicate initial assessments. In addition, social roles and caregiving expectations frequently influence how patients perceive surgical interventions.
Surveys indicate that women with Parkinson's disease frequently decline deep brain stimulation due to personal preference, fear of complications, or lack of home caregiving support. Conversely, male patients often receive strong domestic caregiving support from spouses, facilitating timely surgical decision-making. Furthermore, subtle physician biases can lead to differential counseling patterns during clinic appointments. Clinicians may inadvertently delay discussions about surgical options with female patients until medical therapies completely fail. Therefore, addressing this gap requires proactive educational outreach that directly resolves female patients' concerns regarding perioperative recovery, safety, and domestic support structures.
These findings carry profound implications for movement disorder specialists, general neurologists, and functional neurosurgeons managing advanced Parkinson's disease. Most importantly, clinicians must recognize that clinical efficacy alone does not guarantee equitable patient outcomes. Delayed referral directly compromises postoperative quality of life by increasing susceptibility to cognitive deterioration. Therefore, teams must implement standardized referral screening tools to identify appropriate surgical candidates earlier in disease progression.
Additionally, comprehensive preoperative neuropsychological assessments are critical for female candidates presenting with prolonged disease courses. Clinicians should provide clear, balanced counseling that emphasizes the proven motor benefits of neurostimulation while proactively addressing cognitive vulnerabilities. Moreover, postoperative programming protocols should incorporate individualized cognitive monitoring alongside motor optimization. By integrating formal cognitive screening into routine follow-up visits, teams can detect functional changes promptly and initiate appropriate cognitive rehabilitation. Ultimately, early identification and objective evaluation will ensure that female patients access advanced interventions before preventable non-motor complications emerge.
Eliminating disparities in functional neurosurgery demands coordinated systemic initiatives across healthcare networks. Health systems should establish dedicated movement disorder registries to track referral demographics and detect sex-based attrition points. Furthermore, professional societies must publish updated clinical guidance that explicitly addresses sex-specific disease phenotypes and treatment trajectories. Clinicians should also expand the utilization of awake versus asleep surgical options, as asleep DBS protocols significantly increase female patient acceptance.
In addition, patient advocacy groups must develop targeted educational resources that empower women to discuss device-aided therapies with their physicians. Family counseling should also be integrated into preoperative clinics to alleviate burdens on female patients who lack spousal caregivers. Moving forward, prospective multicenter studies must evaluate long-term cognitive and psychiatric outcomes to refine patient selection criteria. By standardizing referral timelines, addressing personal preferences, and implementing tailored postoperative rehabilitation, the neurology community can achieve true clinical equity for all patients with advanced Parkinson's disease.
Women often experience delayed surgical referrals due to complex clinical and social factors. Clinicians frequently underestimate female symptom severity or delay advanced surgical discussions. Furthermore, women more commonly decline surgery because of personal preferences, fear of procedural complications, and lower rates of domestic caregiving support compared to male patients.
Yes, subthalamic deep brain stimulation provides equal clinical efficacy for motor symptoms in men and women. Both cohorts experience comparable, significant improvements in off-medication motor scores and dopaminergic medication reductions. However, delayed intervention in women can result in worse baseline physical impairment and potentially disparate postoperative cognitive trajectories.
Clinicians should screen female patients for surgical candidacy earlier in their disease course to avoid prolonged disease duration. In addition, comprehensive preoperative neuropsychological assessments, tailored electrode programming, and structured post-surgical cognitive monitoring help clinicians identify subtle changes quickly and implement targeted cognitive rehabilitation strategies to safeguard functional independence.
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References
Faran M et al. Sex disparity in patients with Parkinson's disease treated using deep brain stimulation. J Neurosurg. 2025 Sep 01. doi: 10.3171/2025.1.JNS241670. PMID: 40378492.
Jost ST, Strobel L, Rizos A, et al. Gender gap in deep brain stimulation for Parkinson's disease. NPJ Parkinsons Dis. 2022;8(1):173. doi: 10.1038/s41531-022-00437-0.
Sperens M, Georgiev D, Forsgren L, et al. Sex differences in Parkinson's disease: candidate mechanisms and outcome implications. J Parkinsons Dis. 2020;10(4):1317-1330. doi: 10.3233/JPD-202077.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A retrospective cohort study reveals significant sex differences in Parkinson's disease patients receiving subthalamic deep brain stimulation. Women face delayed referrals, worse baseline motor scores, and post-surgical cognitive decline, despite similar overall motor benefits compared to men.
Today

A validated natural language processing pipeline leverages clinical notes and intermediate annotations to identify risky alcohol use across surgical patients, offering automated preoperative risk stratification.
Today

The GESS-AEEM consensus establishes a clear clinical implementation framework for testosterone therapy in postmenopausal women with hypoactive sexual desire disorder, focusing on transdermal dosing, precise laboratory monitoring, and safety communication.
Yesterday

A rare case of an asymptomatic left ventricular hemangioma highlights the vital role of multimodal imaging in differentiating vascular tumors from thrombus. Complete surgical resection under transesophageal echocardiography guidance prevents thromboembolism and delivers optimal outcomes.
Today

A landmark study evaluates long-term quality of life in adolescents and adults with brachial plexus birth injury. Severe functional limitation and limited access to care significantly worsen outcomes, underscoring the urgent need for persistent, multidisciplinary management across adult healthcare transitions.
Today

An analysis of 1,000 posts by macro- and mega-influencers on Instagram and TikTok revealed that 78.5% contained nutrition misinformation, while only 24% of creators held valid credentials. This article examines the clinical risks of viral dietary fads and provides actionable guidance for healthcare professionals.
Today